{
    "nctId": "NCT05181722",
    "briefTitle": "Evaluating the Use of Patient Navigation to Promote Timely Diagnostic Evaluation During the COVID-19 Pandemic",
    "officialTitle": "Evaluating the Use of Patient Navigation to Promote Timely Diagnostic Evaluation During the COVID-19 Pandemic",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
    "enrollmentCount": 196,
    "primaryOutcomeMeasure": "Diagnostic follow-up rates",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients who have an abnormal screening mammogram (i.e. given a Breast Imaging-Reporting and Data System \\[BI-RADS\\] assessment category of 0) at the investigators' institution during the study period and have not yet undergone diagnostic evaluation\n\nExclusion Criteria:\n\n* Any study participant who is unable to provide consent to participate in the study will be excluded.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}